Last year in the UK over 60,000 cancer patients enrolled on clinical trials aimed at improving cancer treatments and making them available to all.
A trial looking at genetic factors in people having chemotherapy for bowel cancer
This trial looked at the genetic material (DNA) of people who had chemotherapy for advanced bowel cancer. This was to see if it affected how well they responded to treatment.
More about this trial
Chemotherapy is the main treatment for people with advanced bowel cancer. It works well for some people, but unfortunately not so well for others. There are a number of theories about why this happens, but no one is quite sure at the moment.
There is increasing evidence about how
The aim of this trial was see if researchers could identify any common factors or genetic faults in people who respond well to chemotherapy, compared to those who don’t.
Summary of results
We have contacted the trial team who have told us that it is unlikely that the results from this trial will be published.
How to join a clinical trial
Prof Angela Cox
Dr Maria Marples
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Weston Park Hospital Cancer Appeal fund